Pancreas Transplantation

Pancreas Transplant - Sweet Relief Quest

• Indications:
  • Type 1 DM with ESRD (most common for SPK)
  • Type 1 DM with recurrent severe metabolic complications (e.g., hypoglycemia, ketoacidosis)
  • Selected Type 2 DM (controversial, specific criteria)
• Goals:
  • Achieve euglycemia & insulin independence
  • Prevent/stabilize secondary diabetic complications (retinopathy, neuropathy, nephropathy)
  • Improve quality of life
• Patient Selection:
  • C-peptide status: Negative or low C-peptide indicates insulin deficiency.
  • BMI: Generally <30 kg/m²
  • Cardiovascular health: Adequate cardiac function essential.
  • Absence of active infection or malignancy.

⭐ Simultaneous Pancreas-Kidney (SPK) transplant is the most common type of pancreas transplant performed worldwide for patients with Type 1 Diabetes and end-stage renal disease (ESRD).

Pancreas Plumbing - Guts & Glory

• Transplant Types:

  • SPK: Simultaneous Pancreas-Kidney (most common; T1DM + ESRD).
  • PAK: Pancreas After Kidney (prior kidney transplant).
  • PTA: Pancreas Transplant Alone (labile T1DM, good renal function).

• Surgical Technique:

  • Vascular Anastomosis:
    • Arterial: Donor iliac artery Y-graft (from donor iliacs) to recipient iliacs.
    • Venous: Donor portal vein to recipient SMV (portal drainage, more physiological) or IVC/iliac vein (systemic drainage).
  • Exocrine Drainage:
    • Enteric (Preferred): Duodenum to jejunum (Roux-en-Y). Pros: More physiological, ↓reflux. Cons: ↑Leak/infection risk.
    • Bladder: Duodenum to bladder. Pros: Easy rejection monitoring (urine amylase). Cons: UTIs, acidosis, hematuria.

⭐ Systemic venous drainage with enteric exocrine drainage is the most common surgical technique.

Rejection Rebuff - Immune Harmony

• Immunosuppression:

  • Induction: Anti-thymocyte globulin (ATG), Alemtuzumab, Basiliximab (IL-2R antagonist).
  • Maintenance:
    • Tacrolimus (CNI): Key SEs - nephrotoxicity, neurotoxicity.
    • Mycophenolate Mofetil (MMF): Key SEs - GI upset, myelosuppression.
    • Steroids (Prednisolone): Key SEs - hyperglycemia, Cushingoid.
    • 📌 Mnemonic: Tacro Myco Stero (Tacrolimus, Mycophenolate, Steroids).

• Monitoring for Rejection:

  • Clinical: Fever, graft tenderness. Hyperglycemia (⚠️ late, often irreversible).
  • Biochemical Markers:
    • ↑ Serum Amylase/Lipase (exocrine dysfunction).
    • ↓ C-peptide, ↑ Blood Glucose (endocrine dysfunction).
    • ↑ HbA1c (glycemic control).

  ⭐ Monitoring serum lipase/amylase is useful, but hyperglycemia is a late and often irreversible sign of pancreas graft rejection.

• Diagnosis of Rejection:

  • Gold Standard: Graft biopsy (percutaneous/endoscopic).

Transplant Troubles - Pancreatic Perils

Surgical Complications:

• Vascular Thrombosis: Arterial or venous; critical early threat, major cause of graft loss.
• Anastomotic Leak: Enteric (duodenal stump) or vascular; can lead to sepsis.
• Graft Pancreatitis: Non-infectious inflammation; monitor amylase/lipase closely.
• Infection: Surgical site, intra-abdominal abscess, or systemic due to immunosuppression.
• Bleeding: Significant risk at anastomoses or from graft parenchyma.
• Duodenal Segment Issues: (If used) Leak, ulceration, bleeding, perforation, obstruction.

Medical Complications:

• Immunosuppression-Related:
  • Nephrotoxicity: Esp. Calcineurin Inhibitors (CNIs) like Tacrolimus.
  • Opportunistic Infections: CMV, BK virus, fungal; prophylaxis is key.
  • Malignancy: Increased risk of PTLD, skin cancers.
• Metabolic:
  • Hyperglycemia/NODAT: Steroid-induced or persistent insulin resistance.
  • Dyslipidemia: Common; requires monitoring and active management.

⭐ Graft thrombosis is the leading cause of technical failure and early pancreas graft loss.

High‑Yield Points - ⚡ Biggest Takeaways

• SPK transplant (Simultaneous Pancreas-Kidney) is the most common type, primarily for Type 1 DM with ESRD.
• Enteric drainage of exocrine secretions is now standard, reducing urological complications.
• Vascular thrombosis (especially venous) is the most frequent cause of early graft failure.
• Acute rejection is common; graft biopsy remains the gold standard for diagnosis.
• Standard immunosuppression includes a calcineurin inhibitor, antimetabolite, and steroids.
• Monitor graft function via glucose levels; amylase/lipase are less specific with enteric drainage.